Lamivudine/zidovudine (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Lamivudine/zidovudine" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

4doi.org

2^nd place

4web.archive.org

1^st place

2handle.net

102^nd place

76^th place

1fda.gov

447^th place

338^th place

1europa.eu

68^th place

117^th place

1semanticscholar.org

11^th place

8^th place

1yale.edu

565^th place

460^th place

1who.int

195^th place

302^nd place

1catie.ca

low place

1viivhealthcare.com

low place

catie.ca

"Combivir". www.catie.ca. Archived from the original on 8 November 2016. Retrieved 8 November 2016.

doi.org

Watts DH, Covington DL, Beckerman K, Garcia P, Scheuerle A, Dominguez K, et al. (September 2004). "Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy". American Journal of Obstetrics and Gynecology. 191 (3): 985–992. doi:10.1016/j.ajog.2004.05.061. PMID 15467577.
Esser S, Helbig D, Hillen U, Dissemond J, Grabbe S (September 2007). "Side effects of HIV therapy". Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology. 5 (9): 745–754. doi:10.1111/j.1610-0387.2007.06322.x. PMID 17760894. S2CID 10271162.
Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al. (January 2000). "Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel". JAMA. 283 (3): 381–390. doi:10.1001/jama.283.3.381. PMID 10647802.
Breckenridge, Alasdair (June 2005). "Pharmacology of drugs for HIV". Medicine. 33 (6): 30–31. doi:10.1383/medc.33.6.30.66012.

europa.eu

ema.europa.eu

"Combivir EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 29 May 2020.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

handle.net

hdl.handle.net

World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 157, 161. hdl:10665/44053. ISBN 9789241547659.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

nih.gov

pubmed.ncbi.nlm.nih.gov

Watts DH, Covington DL, Beckerman K, Garcia P, Scheuerle A, Dominguez K, et al. (September 2004). "Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy". American Journal of Obstetrics and Gynecology. 191 (3): 985–992. doi:10.1016/j.ajog.2004.05.061. PMID 15467577.
Portsmouth SD, Scott CJ (August 2007). "The renaissance of fixed dose combinations: Combivir". Therapeutics and Clinical Risk Management. 3 (4): 579–583. PMC 2374941. PMID 18472979.
Esser S, Helbig D, Hillen U, Dissemond J, Grabbe S (September 2007). "Side effects of HIV therapy". Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology. 5 (9): 745–754. doi:10.1111/j.1610-0387.2007.06322.x. PMID 17760894. S2CID 10271162.
Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al. (January 2000). "Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel". JAMA. 283 (3): 381–390. doi:10.1001/jama.283.3.381. PMID 10647802.
Portsmouth SD, Scott CJ (August 2007). "The renaissance of fixed dose combinations: Combivir". Therapeutics and Clinical Risk Management. 3 (4): 579–583. PMC 2374941. PMID 18472979.

ncbi.nlm.nih.gov

Portsmouth SD, Scott CJ (August 2007). "The renaissance of fixed dose combinations: Combivir". Therapeutics and Clinical Risk Management. 3 (4): 579–583. PMC 2374941. PMID 18472979.
Portsmouth SD, Scott CJ (August 2007). "The renaissance of fixed dose combinations: Combivir". Therapeutics and Clinical Risk Management. 3 (4): 579–583. PMC 2374941. PMID 18472979.

dailymed.nlm.nih.gov

"Combivir- lamivudine and zidovudine tablet, film coated". DailyMed. 10 May 2019. Retrieved 29 May 2020.

semanticscholar.org

api.semanticscholar.org

Esser S, Helbig D, Hillen U, Dissemond J, Grabbe S (September 2007). "Side effects of HIV therapy". Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology. 5 (9): 745–754. doi:10.1111/j.1610-0387.2007.06322.x. PMID 17760894. S2CID 10271162.

viivhealthcare.com

"Combivir | ViiV Healthcare". www.viivhealthcare.com. Archived from the original on 5 May 2016. Retrieved 8 November 2016.

web.archive.org

"Drugs for HIV Infection" (PDF). The Medical Letter, Inc. October 2006. Archived from the original (PDF) on 5 March 2017. Retrieved 9 November 2016.
"Summary of Product Characteristics: Lamivudine, Nevirapine and Zidovudine Tablets" (PDF). May 2011. Archived from the original (PDF) on 9 November 2016.
"Combivir". www.catie.ca. Archived from the original on 8 November 2016. Retrieved 8 November 2016.
"Combivir | ViiV Healthcare". www.viivhealthcare.com. Archived from the original on 5 May 2016. Retrieved 8 November 2016.

who.int

apps.who.int

"Summary of Product Characteristics: Lamivudine, Nevirapine and Zidovudine Tablets" (PDF). May 2011. Archived from the original (PDF) on 9 November 2016.

yale.edu

medicine.yale.edu

"Drugs for HIV Infection" (PDF). The Medical Letter, Inc. October 2006. Archived from the original (PDF) on 5 March 2017. Retrieved 9 November 2016.